Coronavirus vaccine: A tool to protect Western interests in Africa
The US and Europe are using the coronavirus vaccine to pursue their own expansionist policies in poor countries, thanks to the monopoly of this vital commodity at the most golden time since its discovery and production.
Despite the repeated recommendations for equitable distribution of the vaccine, Western nations had been reluctant to share the vaccine with less developed nations.
However, as those wealthy countries vaccinated the majority of their populations, there is now talk of a fair distribution of vaccines.
The President of France, Emmanuel Macron, whose country has largely overcome the initial concerns about vaccination and the fight against Covid-19, seeks to exploit this opportunity to expand its influence in Africa.
However, the world has not yet forgotten the hostile competition of Western countries in the early months of the deadly outbreak in seizing and stealing shipments of masks and disinfectants from each other.
Now, however, the wealthy Western countries, after splitting the vaccines among themselves, intend to achieve their hegemonic goals from the surplus of these vaccines, which are not very cheap to maintain and store.
Macron recently spoke of the need to distribute vaccines in poor countries. His remarks come at a time when even children in rich
countries are being vaccinated. According to the World
Health Organization, there is no urgency for vaccinating kids, and priority
must be given to adults, especially in low-income countries, which lack
adequate health facilities, such as some African countries.
So far, only 28 million COVID-19 doses of different vaccines have been administered in Africa, a continent of 1.4 billion people. The WHO says Africa needs at least 20 million second doses of the vaccines by mid-July to give everyone who has received the first dose full immunity.
According to the latest published data, nearly 25 million of French
citizens have received the first dose, which covers about 38% of the country's
population, and almost 12 million people have received the second dose, which is equivalent to 17% of the French population.
These statistics show that France feels comfortable about its vaccination campaign and seeks to use vaccines and financial aid to Africa to expand its waning Influence and eliminate competitors in this fast-growing region.